1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corporation

NMTC
NeuroOne Medical Technologies CorporationUS flagNASDAQ Capital Market
3.47
USD
-0.09
- -
29.91MMarket Cap

Total Valuation

NeuroOne Medical Technologies Corporation carries a market capitalization of 29.91M, placing it among publicly traded companies globally. Its enterprise value stands at 36.20M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap29.91M
Enterprise Value36.20M

Share Statistics

NeuroOne Medical Technologies Corporation currently has 8.62M shares outstanding.

Shares Outstanding8.62M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 3.99, and the price-to-book ratio stands at -0.47.

PE RatioN/A
PS Ratio3.99
PB Ratio-0.47
P/TBV Ratio7.26
P/FCF Ratio-5.31
P/OCF Ratio-5.22

Enterprise Valuation

EV / Sales3.72
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

NeuroOne Medical Technologies Corporation maintains a current ratio of 4.38, meaning it holds 4.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.85, indicating elevated leverage, while an interest coverage ratio of -730.22 demonstrates limited ability to service its debt obligations.

Current Ratio4.38
Quick Ratio3.10
Debt / Equity3.85
Debt / EBITDA-0.03
Interest Coverage-730.22

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-107.84
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.39

Stock Price Statistics

NeuroOne Medical Technologies Corporation's stock has gained approximately 3.89222% over the past 52 weeks. The 50-day moving average sits at 4.44, while the 200-day moving average is 4.68.

Beta (5Y)N/A
52-Week Price Change3.89222%
50-Day Moving Average4.44
200-Day Moving Average4.68
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, NeuroOne Medical Technologies Corporation generated 9.72M in revenue and converted that into -6.64M in net income, yielding earnings per share of -0.80. EBITDA reached -6.81M, while operating income came in at -7.07M.

Revenue9.72M
Gross Profit5.30M
Operating Income-7.07M
Pretax Income-6.64M
Net Income-6.64M
EBITDA-6.81M
EBIT-7.07M
Earnings Per Share (EPS)-0.80

Balance Sheet

NeuroOne Medical Technologies Corporation holds 2.80M in cash and equivalents against 206,973.00 in total debt, resulting in a net debt position of -2.80M. Total book value stands at -82.12M, with working capital of 5.71M providing operational flexibility.

Cash & Cash Equivalents2.80M
Total Debt206,973.00
Net Debt-2.80M
Equity (Book Value)-82.12M
Book Value Per Share-9.87
Working Capital5.71M

Cash Flow

NeuroOne Medical Technologies Corporation produced -7.43M in operating cash flow over the past twelve months. After subtracting -133,425.00 in capital expenditures, free cash flow totaled -7.57M - equivalent to -0.91 per share.

Operating Cash Flow-7.43M
Capital Expenditures-133,425.00
Free Cash Flow-7.57M
FCF Per Share-0.91

Margins

NeuroOne Medical Technologies Corporation operates with a gross margin of 54.50, reflecting its pricing power and cost economics. The operating margin of -72.69 and net profit margin of -68.34 provide insight into operational efficiency.

Gross Margin54.50
Operating Margin-72.69
Pretax Margin-68.34
Profit Margin-68.34
EBITDA Margin-70.05

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-23.33
FCF Yield-18.82

Stock Splits

NeuroOne Medical Technologies Corporation's most recent stock split took place on April 16, 2026 with a 6:1 split ratio.

Last Split Date4/16/2026
Split Ratio6:1

Scores

NeuroOne Medical Technologies Corporation posts an Altman Z-Score of -6.20, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-6.20